Skape Bio ApS is a Danish APS based in København N, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2025, the company has 13 employees and reported a gross profit of -DKK 3.6m in its latest annual filing.
EBITDA margin (of gross profit) 202.7 %
Solidity ratio Equity ÷ Total assets × 100 Among the 20% lowest rated companies in the industry
2025 2025
Liquidity ratio Current assets ÷ Short-term debt Among the 10% highest rated companies in the industry
2025 2025
Return on assets (ROA) Net profit ÷ Total assets × 100 Among the 20% lowest rated companies in the industry
2025 2025
EBITDA — year on year DKK thousands 0 -2263 -4526 -6789 -9052 2025: -7269 -7269 2025
Key figures Annual report 2025 Gross profit -3.6M DKK — EBITDA -7.3M DKK — Net profit -6.4M DKK — Total assets 36.1M DKK — Equity -6.4M DKK — Employees 13 —
Founded
13 March 2025 · 1 year
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør eller af den samlede bestyrelse i forening.
Company purpose
Selskabets formål er at beskæftige sig med forskning og udvikling af immaterielle rettigheder relateret til proteindesign og -teknologi, lægemiddeludvikling samt relaterede tjenester og aktiviteter.
(no translation available)
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Explore Financial development In its most recent annual report (2025), Skape Bio ApS reported a gross profit of -DKK 3.6m. The bottom line showed a net loss of DKK 6.4m.
At the end of 2025, current assets covered short-term debt 50.2 times. Skape Bio ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
Frequently asked questions What is the CVR number of Skape Bio ApS? Skape Bio ApS is registered with CVR / Virk under CVR 45471071.
What is the gross profit of Skape Bio ApS? Skape Bio ApS reported a gross profit of -DKK 3.6m in 2025.
How many employees does Skape Bio ApS have? Skape Bio ApS employs 13 people as of the latest annual report.
Who is the CEO of Skape Bio ApS? Christoffer Norn is the CEO of Skape Bio ApS.
Who is the chairman of Skape Bio ApS? Lansing Joseph Stewart chairs the board of Skape Bio ApS.
Where is Skape Bio ApS headquartered? Skape Bio ApS's registered address is Ole Maaløes Vej 3.
